{"title":"唐氏综合症患者的强迫症治疗:一个病例系列。","authors":"Bruce Sutor, Mark R Hansen, John L Black","doi":"10.3104/case-studies.299","DOIUrl":null,"url":null,"abstract":"<p><p>In this case series we report four cases of patients with Down syndrome with symptoms consistent with obsessive compulsive disorder. Each patient experienced substantial reduction in compulsive behaviors with pharmacotherapy of an SSRI alone or with the addition of risperidone to SSRI therapy. None of the patients experienced significant side effects. This small case series supports the use of these medications in the treatment of co-morbid obsessive compulsive disorder in patients with Down syndrome.</p>","PeriodicalId":80275,"journal":{"name":"Down's syndrome, research and practice : the journal of the Sarah Duffen Centre","volume":"10 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2006-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"16","resultStr":"{\"title\":\"Obsessive compulsive disorder treatment in patients with Down syndrome: a case series.\",\"authors\":\"Bruce Sutor, Mark R Hansen, John L Black\",\"doi\":\"10.3104/case-studies.299\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this case series we report four cases of patients with Down syndrome with symptoms consistent with obsessive compulsive disorder. Each patient experienced substantial reduction in compulsive behaviors with pharmacotherapy of an SSRI alone or with the addition of risperidone to SSRI therapy. None of the patients experienced significant side effects. This small case series supports the use of these medications in the treatment of co-morbid obsessive compulsive disorder in patients with Down syndrome.</p>\",\"PeriodicalId\":80275,\"journal\":{\"name\":\"Down's syndrome, research and practice : the journal of the Sarah Duffen Centre\",\"volume\":\"10 1\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"16\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Down's syndrome, research and practice : the journal of the Sarah Duffen Centre\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3104/case-studies.299\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Down's syndrome, research and practice : the journal of the Sarah Duffen Centre","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3104/case-studies.299","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Obsessive compulsive disorder treatment in patients with Down syndrome: a case series.
In this case series we report four cases of patients with Down syndrome with symptoms consistent with obsessive compulsive disorder. Each patient experienced substantial reduction in compulsive behaviors with pharmacotherapy of an SSRI alone or with the addition of risperidone to SSRI therapy. None of the patients experienced significant side effects. This small case series supports the use of these medications in the treatment of co-morbid obsessive compulsive disorder in patients with Down syndrome.